January 14, 2020 3:47 am
The draft National Policy for Rare Diseases proposes a digital platform for bringing together notified hospitals with such patients and prospective donors.
December 11, 2019 4:36 am
Vildagliptin, which belongs to DPP-4 class of drugs, was launched in India in 2008 for treating type-2 diabetes.
October 22, 2019 3:31 am
Wockhardt’s payables have been on the rise over the last three years, with the company reporting over Rs 800 crore in trade payables at the end of March 31, 2019.
August 15, 2019 4:36 am
Central Drugs Standard Control Organisation this month labelled these batches as “not of standard quality” for failing tests conducted in July.
April 25, 2019 2:42 am
Sun Pharma got Form 483 which is issued when investigators observe conditions they deem to be violations of US drug regulations.
March 29, 2019 3:19 am
The findings have caused a public health activist to urge the Delhi High Court to direct the government to initiate “criminal” proceedings against the medicine’s manufacturer — Mankind Pharmaceuticals Ltd.
November 21, 2018 6:35 am
According to the estimates of the National Pharmaceutical Pricing Authority (NPPA), patients across the country have saved around Rs 15,000 crore under the government’s initiative of ensuring affordable, quality medicines for all, Minister of State for Chemicals and Fertilisers Mansukh L Mandaviya said in a statement.
August 30, 2018 1:37 am
The letter dated August 27, states that “we have come to know from reliable market sources that your company’s MR/manager comes in the month-end to complete primary target” and then this employee is “adjusting” by paying from his incentives/salary, which is “highly objectionable and warrant your immediate attention”.
August 07, 2018 1:21 am
CDSCO has also requested state drug regulators to sensitise its inspectorate staff “to keep strict vigil on manufacture, sale and distribution of Oxytocin in the country”.
August 06, 2018 12:29 am
From September 1, only Karnataka Antibiotics & Pharmaceuticals, a public sector entity, would be permitted to manufacture and distribute Oxytocin.